PT-141 10MG

Description

Bremelanotide (or PT-141) is a compound which is developed for the treatment of female sexual dysfunction, hemorrhagic shock and reperfusion injury. It acts by activating the MC1R and MC4R melanocortin receptors, modulating inflammation and limiting ischemia.  Initially, the drug was studied for intranasal use for female sexual dysfunction treatment, but in 2008 development of the drug for such use was temporarily discontinued after reports of adverse side effects associated with increased blood pressure. As of March 2012, Palatin technologies was conducting a phase 2B study in human beings using subcutaneous injection of the drug, which the manufacturer claims will have a very small effect on blood pressure. 

Bremelanotide was developed from the peptide hormone Melanotan 2, which has been investigated as a tanning agent without sun exposure. Melanotan 2 was shown in initial testing to induce sexual arousal and spontaneous erections in addition to tanning.  Bremelanotide has been shown in studies to be effective in the treatment of sexual dysfunction in both men (erectile dysfunction) and women (sexual arousal disorder. Unlike Sildenafail/Tadalafil and other related drugs, Bremelanotide does not effect the vascular system, but increases desire directly through its effect on the nervous system. 

Purpose to use

Used in male or female sexual dysfunction 

Storage 

• The resulting solution can be stored for approximately 21 days in a refrigerator at a temperature of 2-8 degree Celsius. The storage time increases if the solution was prepared using bacteriostatic water.